Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net loss	$ (77,685)	$ (125,703)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	12,519	12,229
Provision for (recovery of) doubtful accounts	(481)	48,955
Impairment loss on intangible assets and goodwill	0	57,232
Gain on extinguishment of debt	(4,891)	(81,354)
Loss on divestiture of business	5,331	0
Change in fair value of private warrant liability	(1,026)	(360)
Change in fair value of contingent consideration	(300)	(2,810)
Change in fair value of derivatives	6,724	2,950
Stock-based compensation	12,473	13,298
Non-cash interest expense	17,313	9,828
Gain on settlement of contingent consideration	(14,930)	0
Other	(1,882)	805
Change in operating assets and liabilities, net of acquisitions and divestitures
Accounts receivable	(1,548)	1,030
Reinsurance balance due	(20,042)	(21,651)
Deferred policy acquisition costs	10,895	(9,187)
Accounts payable	(5,627)	2,929
Accrued expenses and other current liabilities	(7,827)	(10,906)
Losses and loss adjustment expense reserves	37,717	65,077
Other insurance liabilities, current	35,615	51,139
Deferred revenue	(25,693)	(13,491)
Refundable customer deposits	(3,594)	(8,061)
Other assets and liabilities, net	9,434	(726)
Net cash used in operating activities	(17,505)	(8,777)
Cash flows from investing activities:
Purchases of property and equipment	(86)	(672)
Capitalized internal use software development costs	(5,458)	(4,735)
Purchases of short-term and long-term investments	(19,193)	(23,602)
Maturities, sales of short-term and long-term investments	22,631	23,033
Cash proceeds	10,870	0
Acquisitions, net of cash acquired	0	(1,974)
Net cash provided by (used in) investing activities	8,764	(7,950)
Cash flows from financing activities:
Proceeds from advance funding	0	316
Repayments of advance funding	0	(2,683)
Proceeds from issuance of debt	0	116,667
Repayments of principal	(3,150)	(10,150)
Cash paid for debt issuance costs	0	(4,610)
Repurchase of stock	0	(5,608)
Other	24	(960)
Net cash provided by (used in) financing activities	(3,126)	92,972
Net change in cash and cash equivalents & restricted cash and cash equivalents	(11,867)	76,245
Cash and cash equivalents & restricted cash and cash equivalents, beginning of period	297,232	228,605
Cash and cash equivalents & restricted cash and cash equivalents, end of period	285,365	304,850
Supplemental schedule of non-cash investing and financing activities
Non-cash reduction of convertible notes	5,000	0
Non-cash reduction in advanced funding arrangement obligations	94	7,848
Supplemental disclosures
Cash paid for interest	12,056	2,276
Income tax refunds paid (received)	$ 538	$ (2,300)